Ripk1/Ripk3 associated with marked neuroinflammation in animal models of diseases such as multiple sclerosis (56), amyotrophic lateral sclerosis (57) and Alzheimer’s disease (34) and their inhibition improved the disease phenotype. This evidence concerns the gene RIPK1 and early-onset autosomal dominant Alzheimer disease.